Free Breath, Free Life!
AeproMED is an inhaled drug delivery company in personal medicine for chronic disease.
AirHyper Platform
We provide a patient-centric inhalation treatment platform.
More efficient inhaled medicine to your lung.
Auto-record actional data feedback to patients, clinicials.
Digital monitor to deliver medicine with patient’s breath pattern.
Advantages of Techniques
Aerosol Variable-frequency Transport Technology (AVTT)
Our technology could shorten the time of inhaling the medicine, improving drug delivery efficiency even to different features of medicine. We consider illness patients suffering from breathing issues, optimized delivery performance with the patient’s breathing pattern.
Shorten time
Auto-optimized to easy use
Consideration design with
patient’s breath pattern
Stakeholders
Patients
Patients
Clinicians /Hospital
Clinicians /Hospital
Pharma
Pharma
Investors
Investors
News&Insights
Is the Next Great COVID Vaccine an Inhaled One?
TUESDAY, Feb. 15, 2022 (HealthDay News) — “The jab” might soon be replaced with something like “
Is the Next Great COVID Vaccine an Inhaled One?
TUESDAY, Feb. 15, 2022 (HealthDay News) — “The jab” might soon be replaced with something like “
Is the Next Great COVID Vaccine an Inhaled One?
TUESDAY, Feb. 15, 2022 (HealthDay News) — “The jab” might soon be replaced with something like “
Is the Next Great COVID Vaccine an Inhaled One?
TUESDAY, Feb. 15, 2022 (HealthDay News) — “The jab
Is the Next Great COVID Vaccine an Inhaled One?
TUESDAY, Feb. 15, 2022 (HealthDay News) — “The jab
Is the Next Great COVID Vaccine an Inhaled One?
TUESDAY, Feb. 15, 2022 (HealthDay News) — “The jab
Contact us
We‘d love to tell you more about AeProMED…
